Baseline characteristics of study participants with and without incident atrial fibrillation at baseline examination
All subjects n=1599 | Subjects without incident AF n=1321 | Subjects with incident AF n=278 | P value | |
Age (years) | 67.3 (±6.0) | 66.8 (±6.0) | 69.7 (±5.3) | <0.001 |
Sex (n female (%)) | 475 (29.7) | 401 (30.4) | 74 (26.6) | 0.205 |
Smoking (n (%)) | 287 (17.9) | 244 (18.5) | 43 (15.5) | 0.661 |
AHT (%) | 714 (44.7) | 552 (41.8) | 162 (58.3) | <0.001 |
BMI (kg/m2) | 28.3 (±4.3) | 28.0 (±4.2) | 29.5 (±4.9) | <0.001 |
SBP (mm Hg) | 147.1 (±20.2) | 147.1 (±20.2) | 147.2 (±20.3) | 0.959 |
Prevalent diabetes (n (%)) | 639 (40.0) | 500 (37.9) | 139 (50.0) | <0.001 |
Prevalent CVD (n (%)) | 156 (9.8) | 116 (8.8) | 40 (14.4) | 0.004 |
Prevalent HF (n (%)) | 16 (1.0) | 11 (0.8) | 5 (1.8) | 0.081 |
Values are displayed as means (±SD) or, for skewed variables, medians and IQR (25–75).
AF, atrial fibrillation; AHT, antihypertensive treatment; BMI, body mass index; CVD, cardiovascular disease; HF, heart failure; SBP, systolic blood pressure.